Development of a New Analgesic Based on Metabolism of Endomorphin, an Endogenous Opioid Peptide
基于内吗啡(一种内源性阿片肽)代谢的新型镇痛药的开发
基本信息
- 批准号:15590086
- 负责人:
- 金额:$ 2.3万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2003
- 资助国家:日本
- 起止时间:2003 至 2004
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Endomorphin-2 (Tyr-Pro-Phe-PheNH_2) was discovered as an endogenous ligand for the mu-opioid receptor. The physiological function of endomorphin-2 as a neurotransmitter or neuromodulator may cease through the rapid enzymatic process in the synapse of brain, as for other neuropeptides. The present study was conducted to examine the metabolism of endomorphin-2 by synaptic membranes prepared from mouse brain. Major metabolites were free tyrosine, free phenylalanine, Tyr-Pro and PheNH_2. Both the degradation of endomorphin-2 and the accumulation of major metabolites were inhibited by specific inhibitors of dipeptidyl peptidase IV, such as diprotin A and B. On the other hand, the accumulation of Phe-PheNH_2 and Pro-Phe-PheNH_2 was increased in the presence of bestatin, an aminopeptidase inhibitor, whereas that of free phenylalanine and PheNH_2 was decreased. Furthermore, purified dipeptidyl peptidase IV hydrolyzed endomorphin-2 at the cleavage site, Pro^2-Phe^3 bond. Thus, degradation of endomorphin-2 by brain synaptic membranes seems to take place mainly through the cleavage of Pro^2-Phe^3 bond by dipeptidyl peptidase IV, followed by release of free phenylalanine and Phe NH_2 from the liberated fragment, Phe-Phe NH_2 by aminopeptidase. We have also examined that the effect of diprotin A on the antinociception induced by intracerebroventricularly administered endomorphin-2 in the mouse paw withdrawal test. Diprotin A simultaneously injected with endomorphin-2 enhanced endomorphin-2-induced antinociception. These results indicate that dipeptidyl peptidase IV may be an important peptidase responsible for terminating endomorphin-2-induced antinociception at the supraspinal level in mice. These findings also suggest that selective dipeptidyl peptidase IV inhibitors or dipeptidyl peptidaseIV-resistant endomorphin-2 analogues have the potential for the clinical use as analgesics.
内吗啡肽-2(Tyr-Pro-Phe-PheNH_2)是μ-阿片受体的内源性配体。内吗啡肽-2作为神经递质或神经调质的生理功能可能与其他神经肽一样,通过脑突触中的快速酶促过程而终止。本研究旨在研究内吗啡肽-2在小鼠脑突触膜上的代谢。主要代谢产物为游离酪氨酸、游离苯丙氨酸、Tyr-Pro和PheNH_2。内吗啡肽-2的降解和主要代谢产物的积累都被二肽基肽酶IV的特异性抑制剂如diprotin A和B抑制。而苯丙氨酸和苯丙氨酸氨解氨酶抑制剂bestatin的存在则使Phe-PheNH_2和Pro-Phe-PheNH_2的积累增加,而使游离苯丙氨酸和PheNH_2的积累减少。此外,纯化的二肽基肽酶IV在切割位点Pro^2-Phe^3键处水解内吗啡肽-2。因此,脑突触膜对内吗啡肽-2的降解似乎主要是通过二肽基肽酶IV切割Pro^2-Phe^3键,然后通过氨肽酶从释放的片段Phe-Phe NH_2中释放游离苯丙氨酸和Phe NH_2来进行的。我们还在小鼠缩爪实验中检测了双蛋白A对侧脑室注射内吗啡肽-2诱导的抗伤害性感受的作用。同时注射内吗啡肽-2可增强内吗啡肽-2诱导的抗伤害作用。这些结果表明,二肽基肽酶IV可能是一个重要的肽酶负责终止内吗啡肽-2诱导的抗伤害性在脊髓上水平的小鼠。这些发现也表明,选择性二肽基肽酶IV抑制剂或二肽基肽酶IV抗性内吗啡肽-2类似物具有作为镇痛剂的临床应用的潜力。
项目成果
期刊论文数量(6)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Degradation of endomorphin-2 at the supraspinal level in mice is initiated by dipeptidyl peptidase IV : an in vitro and in vivo study
二肽基肽酶 IV 启动小鼠脊髓上水平内吗啡-2 的降解:一项体外和体内研究
- DOI:
- 发表时间:2003
- 期刊:
- 影响因子:0
- 作者:Suganuma;M. et al.;Satoshi Akiba;Nobuaki Mizutani;Chikai Sakurada 他5名
- 通讯作者:Chikai Sakurada 他5名
Development of a new analgesic based on metabolism of endomorphin, an endogenous opioid peptide
开发基于内吗啡(一种内源性阿片肽)代谢的新型镇痛药
- DOI:
- 发表时间:2004
- 期刊:
- 影响因子:0
- 作者:J.Mori;T.Hayashi;M.Iwashima;T.Matsunaga;H.Saito;Chikai Sakurada
- 通讯作者:Chikai Sakurada
Chikai Sakurada 他: "Degradation of endomorphin-2 at the supraspinal level in mice is initiated by dipeptidyl peptidase IV : an in vitro and in vivo study"Biochemical Pharmacology. 66. 653-661 (2003)
Chikai Sakurada 等人:“二肽基肽酶 IV 引发小鼠脊髓上水平的内啡肽-2 降解:一项体外和体内研究”《生化药理学》66. 653-661 (2003)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SAKURADA Chikai其他文献
SAKURADA Chikai的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SAKURADA Chikai', 18)}}的其他基金
Development of anti-dementia drugs based on metabolism of nociceptin by synaptic membranes of hippocampus.
基于海马突触膜代谢伤害感受素开发抗痴呆药物。
- 批准号:
18590068 - 财政年份:2006
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
Active involvements of glucagon-like peptide-1 (GLP-1) / dipeptidyl peptidase IV (DPP4) system in the development of renal injury in a rat model of chronic kidney disease (CKD).
胰高血糖素样肽-1 (GLP-1)/二肽基肽酶 IV (DPP4) 系统积极参与慢性肾病 (CKD) 大鼠模型肾损伤的发生。
- 批准号:
26860653 - 财政年份:2014
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Role for Dipeptidyl Peptidase-IV in the Innate Immune Response
二肽基肽酶-IV 在先天免疫反应中的作用
- 批准号:
nhmrc : 1016662 - 财政年份:2011
- 资助金额:
$ 2.3万 - 项目类别:
Early Career Fellowships
P4-ROLE OF DIPEPTIDYL PEPTIDASE IV IN PERIPHERAL NEUROGENESIS AND NEUROBLASTOMAS
P4-二肽基肽酶 IV 在外周神经发生和神经母细胞瘤中的作用
- 批准号:
8168062 - 财政年份:2010
- 资助金额:
$ 2.3万 - 项目类别:
P4-ROLE OF DIPEPTIDYL PEPTIDASE IV IN PERIPHERAL NEUROGENESIS AND NEUROBLASTOMAS
P4-二肽基肽酶 IV 在外周神经发生和神经母细胞瘤中的作用
- 批准号:
7959689 - 财政年份:2009
- 资助金额:
$ 2.3万 - 项目类别:
STRUCTURE/ PHARMACOLOGY OF KING COBRA DIPEPTIDYL PEPTIDASE IV & COTTONMOUTH VENOM
眼镜王蛇二肽基肽酶 IV 的结构/药理学
- 批准号:
7667994 - 财政年份:2008
- 资助金额:
$ 2.3万 - 项目类别:
Therapeutic potential of the dipeptidyl peptidase IV gene family
二肽基肽酶 IV 基因家族的治疗潜力
- 批准号:
nhmrc : 512282 - 财政年份:2008
- 资助金额:
$ 2.3万 - 项目类别:
NHMRC Project Grants
P4-ROLE OF DIPEPTIDYL PEPTIDASE IV IN PERIPHERAL NEUROGENESIS AND NEUROBLASTOMAS
P4-二肽基肽酶 IV 在外周神经发生和神经母细胞瘤中的作用
- 批准号:
7725303 - 财政年份:2008
- 资助金额:
$ 2.3万 - 项目类别:
P4-ROLE OF DIPEPTIDYL PEPTIDASE IV IN PERIPHERAL NEUROGENESIS AND NEUROBLASTOMAS
P4-二肽基肽酶 IV 在外周神经发生和神经母细胞瘤中的作用
- 批准号:
7609873 - 财政年份:2007
- 资助金额:
$ 2.3万 - 项目类别:
Neuropeptide Y and dipeptidyl-peptidase IV (CD26) in chronic fatigue syndrome
神经肽 Y 和二肽基肽酶 IV (CD26) 在慢性疲劳综合征中的作用
- 批准号:
7126969 - 财政年份:2006
- 资助金额:
$ 2.3万 - 项目类别:
Neuropeptide Y and dipeptidyl-peptidase IV (CD26) in chronic fatigue syndrome
神经肽 Y 和二肽基肽酶 IV (CD26) 在慢性疲劳综合征中的作用
- 批准号:
7296144 - 财政年份:2006
- 资助金额:
$ 2.3万 - 项目类别: